UNSPSC 51281616: Kanamycin

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RUC37XUP2P. European Medicines Agency schedules Kanamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08362MIG. Kanamycin generally arises in the molecular formula C18H36N4O11.

UNSPSC 51281616 Kanamycin, a Commodity code, reflects state and local procurement of pharmaceutical products through cooperative purchasing vehicles and direct supply contracts. However, the recent opportunities tagged under this code show limited direct alignment with kanamycin specifically. The Illinois Department of Public Health awarded a piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—both antibiotics but not kanamycin—with a total contract value of $2,999,999.11 over three years including renewal options. Separately, Seminole County, Florida issued an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, which falls outside antibiotic procurement entirely. State and local health departments and county public health agencies appear to be the primary issuing bodies under this code tier, procuring pharmaceutical inventory through competitive bidding and consortial piggyback arrangements to support community health and emergency response functions.

Activity under UNSPSC 51281616 concentrates in Florida and Illinois based on recent postings. The Illinois Department of Public Health contract, awarded in August 2026, represents the most recent opportunity and involved an IFB process with a 12-month initial term and two renewal options. The Seminole County procurement, posted in June 2026 with a July 26 response deadline, specified quarterly delivery requirements and FEMA funding potential. Neither recent opportunity explicitly solicited kanamycin; the code's tagging appears to reflect broader pharmaceutical procurement categorization rather than specific antibiotic compounds. Vendors pursuing this code should verify that active solicitations align with kanamycin supply or related aminoglycoside antibiotics before committing resources to bid preparation.